From: Liver function markers predict cardiovascular and renal outcomes in the CANVAS Program
 | HF | CV death | HF or CV death | All deaths | MACE | Renal endp.a |
---|---|---|---|---|---|---|
Log [baseline] | ||||||
ALT [U/L] | 0.53 [0.34–0.84] | 0.67 [0.47–0.97] | 0.59 [0.44–0.79] | 0.57 [0.43–0.76] | 1.04 [0.81–1.32] | 0.94 [0.72–1.23] |
AST [U/L] | 1.36 [0.79–2.29] | 1.00 [0.63–1.55] | 1.16 [0.81–1.64] | 1.30 [0.91–1.85] | 0.89 [0.66–1.19] | 0.91 [0.66–1.25] |
ALP [U/L] | 1.11 [0.71–1.74] | 1.26 [0.91–1.75] | 1.15 [0.87–1.51] | 1.22 [0.93–1.59] | 1.21 [0.97–1.50] | 1.21 [0.95–1.53] |
γGT [U/L] | 1.51 [1.21–1.86] | 1.22 [1.03–1.44] | 1.34 [1.17–1.53] | 1.24 [1.08–1.42] | 1.12 [1.00–1.26] | 1.00[0.88–1.13] |
Bilirubin [µM] | 1.18 [0.88–1.60] | 0.95 [0.75–1.20] | 1.04 [0.86–1.26] | 0.87 [0.72–1.06] | 1.06 [0.91–1.25] | 1.01 [0.87–1.19] |